BSEM - Company ID 0001658678
The table below shows BIOSTEM TECHNOLOGIES's cash flow statement line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Operating cash flow | $9.94M | $24.46M |
| Capital expenditure | $3.35M | $426.57K |
| Investing cash flow | -$2.10M | -$1.68M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | -$1.12M | -$195.06K |
BIOSTEM TECHNOLOGIES reported operating cash flow of $9.94M for fiscal year 2025. That is down 59.4% from $24.46M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.